<abstract xmlns="http://www.w3.org/1999/xhtml"><p>The treatment of diabetes mellitus type 2 (DM2) is becoming more complex as new medications are approved. Primary care providers must maintain their medical knowledge on emerging medications for best patient care. This review simplifies the non-insulin treatments of diabetes with an emphasis on the cardio-renal protectants, sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1).</p></abstract>

The treatment of diabetes mellitus type 2 (DM2) is becoming more complex as new medications are approved. Primary care providers must maintain their medical knowledge on emerging medications for best patient care. This review simplifies the non-insulin treatments of diabetes with an emphasis on the cardio-renal protectants, sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1).

A practical review of diabetes mellitus type 2 treatment in primary care

Romanian Journal of Internal Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"A practical review of diabetes mellitus type 2 treatment in primary care"}

The treatment of diabetes mellitus type 2 (DM2) is becoming more complex as new medications are approved. Primary care providers must maintain their medical...

A practical review of diabetes mellitus type 2 treatment in primary care

Online veröffentlicht: 17. März 2022

Seitenbereich: 14 - 23

Eingereicht: 18. Juni 2021

DOI: https://doi.org/10.2478/rjim-2021-0031

Schlüsselwörter
diabetes mellitus type 2, sodium-glucose cotransporter 2, glucagon-like peptide 1 receptor agonists

© 2022 Justin T. Call et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

A practical review of diabetes mellitus type 2 treatment in primary care

Online veröffentlicht: 17. März 2022

Seitenbereich: 14 - 23

Eingereicht: 18. Juni 2021

DOI: https://doi.org/10.2478/rjim-2021-0031

Schlüsselwörterdiabetes mellitus type 2, sodium-glucose cotransporter 2, glucagon-like peptide 1 receptor agonists

© 2022 Justin T. Call et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Schlüsselwörter
diabetes mellitus type 2, sodium-glucose cotransporter 2, glucagon-like peptide 1 receptor agonists